Getting your product ready for market.
As late phase clinical studies can become complex, we bring innovation and expertise to minimize delays and mitigate risks in your program.
Leverage our integrated capabilities and global network to accelerate your late clinical development stages and commercial supply. At our facilities in Reading, UK and Philadelphia, PA we have specialized capabilities for late stage manufacturing. Both of these facilities allow for seamless scale-up from the early phases within our network of other global facilities.
Why partner with Quotient Sciences for late phase trials and commercial drug product manufacturing?
Late phase clinical trials must establish the effectiveness, safety, and cost-effectiveness of a product on a larger scale. To help you provide the evidence and quality data for your drug's market approval submission, we offer:
- An integrated scientific team with decades of experience
- Quality clinical data to drive drug product optimization
- One vendor for streamlined outsourcing and a more cost-effective route to market
Learn more about Quotient Sciences' services
See how we can help you with your next drug program.
